Transcat, Inc.

As of October 24, 2025, Transcat, Inc. is in a mildly bearish trend, indicated by bearish weekly MACD and KST signals, despite a bullish monthly RSI, and has underperformed the S&P 500 with year-to-date and annual returns of -25.02% and -35.78%, respectively.

As of October 24, 2025, Transcat, Inc. shows a mildly bearish trend with mixed indicators, having outperformed the S&P 500 recently but underperformed year-to-date.

As of October 17, 2025, Transcat, Inc. is considered very expensive and overvalued, with a P/E ratio of 47, an EV to EBITDA of 20.41, and a year-to-date return of -34.51%, underperforming the S&P 500's 13.30%.

As of October 17, 2025, Transcat, Inc. is considered overvalued with a P/E ratio of 47, a significant decline in stock performance at -46.97% over the past year, and low returns on capital and equity, indicating a shift in market perception from fair to very expensive.

As of September 3, 2025, Transcat, Inc. is in a bearish trend, indicated by negative signals from MACD, moving averages, and KST, while underperforming the S&P 500 with a year-to-date decline of 28.37%.

As of June 30, 2025, Transcat, Inc. is considered very expensive due to high valuation ratios and underperformance compared to the S&P 500, indicating it is overvalued despite a higher P/E ratio among peers.

As of March 28, 2025, Transcat, Inc. is considered very expensive with a P/E ratio of 47 and a current price of $80.27, reflecting overvaluation despite high growth expectations indicated by a PEG ratio of 21.67, while underperforming the S&P 500 with a year-to-date return of -24.09%.

As of June 13, 2025, Transcat, Inc. shows a mildly bearish trend due to daily moving averages indicating bearish momentum, despite some mixed signals from weekly and monthly indicators.

As of March 2022, Transcat, Inc.'s management team includes President and CEO Mr. Lee Rudow, along with several independent directors: Mr. Charles Hadeed (Chairman), Ms. Oksana Dominach, Mr. Richard Harrison, Mr. Gary Haseley, Mr. Paul Moore, and Ms. Angela Panzarella.

Transcat, Inc. provides calibration and laboratory instrument services and distributes test and measurement instrumentation, with recent net sales of $77 million and a market cap of $746.91 million. Key financial metrics include a P/E ratio of 47.00 and a return on equity of 5.39%.

As of Jun 18, Transcat, Inc. has a market capitalization of 746.91 million and net sales of 278.42 million with a net profit of 14.52 million over the latest four quarters. Shareholder's funds are reported at 286.88 million and total assets at 394.99 million as of Mar 25.